Dose-escalated brachytherapy best treatment for unfavourable-risk localised prostate cancer

Combination of pazopanib and paclitaxel safe in urothelial cancer

Tackling renal cancer with a combination of autologous immunotherapy and sunitinib

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

mRCC: Real-world experience: achieving efficacy beyond clinical trials

mRCC: Are we doing all we can to manage adverse events?

mRCC: Understanding the patient's perspective

mRCC: Panel discussion

mRCC: Closing remarks

A short tour of the p-medicine Biovista Correlation Viewer Tool

A short tour of the p-medicine ObTiMA Tool